A detailed history of Tredje Ap Fonden transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tredje Ap Fonden holds 29,330 shares of BMRN stock, worth $1.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,330
Previous 29,330 -0.0%
Holding current value
$1.95 Million
Previous $2.41 Million 14.62%
% of portfolio
0.02%
Previous 0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$74.43 - $92.22 $34,461 - $42,697
-463 Reduced 1.55%
29,330 $2.41 Million
Q4 2023

Feb 12, 2024

SELL
$76.22 - $98.51 $90,320 - $116,734
-1,185 Reduced 3.83%
29,793 $2.87 Million
Q3 2023

Nov 09, 2023

SELL
$85.07 - $94.48 $245,256 - $272,385
-2,883 Reduced 8.51%
30,978 $2.74 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $480,813 - $556,364
-5,547 Reduced 14.08%
33,861 $2.94 Million
Q1 2023

May 10, 2023

BUY
$87.74 - $117.27 $167,934 - $224,454
1,914 Added 5.1%
39,408 $3.83 Million
Q4 2022

Feb 10, 2023

SELL
$80.93 - $108.63 $19,342 - $25,962
-239 Reduced 0.63%
37,494 $3.88 Million
Q3 2022

Nov 10, 2022

BUY
$82.16 - $96.94 $3.1 Million - $3.66 Million
37,733 New
37,733 $3.2 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.